BioSpace News Archive

Business

Elicio Therapeutics Enters Into Merger Agreement with Angion Biomedica

Elicio Therapeutics entered into a merger agreement as a wholly-owned subsidiary of Angion Biomedica Co. on Tuesday, becoming a Nasdaq-listed company.

January 17, 2023
·
1 min read
·
Hayley Shasteen
Deals

Leap Jumps Ahead in Cancer Game with Flame Merger

Massachusetts-based biotech Leap Therapeutics announced Tuesday that it had entered into a merger deal with the privately-held Flame Biosciences, Inc.

January 17, 2023
·
2 min read
·
Tristan Manalac
Business

TC and MD Anderson Partner to Decode Role of GDT Cells in Cancer

TC BioPharm and MD Anderson signed a three-year collaboration to better understand the role of gamma delta T cells in cancer treatment.

January 17, 2023
·
2 min read
·
Heather McKenzie
Drug Development

Edesa Stock Falls Following Mixed Results for Skin Disease Candidate

Edesa Biotech’s EBO1, a monotherapy for moderate-to-severe chronic Allergic Contact Dermatitis (ACD), showed mixed results compared to placebo in Phase II, the company announced Tuesday.

January 17, 2023
·
1 min read
·
Rosemary Scott
Business

Shockwave Acquires Neovasc in $100M Deal

Shockwave Medical bolsters medical device portfolio with acquisition of Neovasc.

January 17, 2023
·
1 min read
·
Hayley Shasteen
Biopharma Freelance Opportunities and Where to Find Them

Freelance workers are a significant component of the biopharma industry. Join us as we take a look at a few biopharma freelancing opportunities and learn where to find them.

January 17, 2023
·
4 min read
·
Franklin Carpenter
Drug Development

Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan

Kinarus Therapeutics AG “Kinarus”, a Swiss clinical-stage biopharmaceutical company announced preclinical data supporting the potential effectiveness of its lead clinical candidate, KIN001, as an oral treatment for idiopathic pulmonary fibrosis.

January 17, 2023
·
4 min read
Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom

RELIEF THERAPEUTICS Holding SA announced independent institutional review board approval for the protocol of an investigator-initiated trial to evaluate RLF-TD011 as an adjunctive treatment for patients diagnosed with cutaneous t-cell lymphoma.

January 17, 2023
·
8 min read
Business

Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs to Accelerate Commercial strategy of IMMray™ PanCan-d test in the US market

Immunovia announced that it has appointed Lara E. Sucheston-Campbell as the Head of Clinical and Medical Affairs effective February 1, 2023.

January 17, 2023
·
2 min read
Business

TISSIUM Appoints Alex Milstein as Chief Medical Officer

TISSIUM, a privately-owned medical technology company developing a portfolio of biomorphic programmable polymers for tissue reconstruction, announced it has appointed Dr. Alex Milstein as its Chief Medical Officer.

January 17, 2023
·
3 min read